Study of stability and biophysical characterization of ranibizumab and aflibercept-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Study of stability and biophysical characterization of ranibizumab and aflibercept

Published:2016-11 Issue: Volume:108 Page:156-167
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Moreno M.R.,Tabitha T.S.,Nirmal J.,Radhakrishnan K.,Yee C.H.,Lim S.,Venkatraman S.,Agrawal R.

Funder

National Thematic Research Grant

National Healthcare Group, Singapore

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference71 articles.

1. Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies;Ciulla;Diabetes Care,2003

2. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis;Wong;Lancet. Glob. Health,2014

3. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen;Chen;J. Mol. Biol.,1999

4. Inhibitors of ocular neovascularization: promises and potential problems;van Wijngaarden;JAMA,2005

5. Genetically engineered fusion proteins for treatment of cancer;Weidle;Cancer Genom. Proteomics,2012

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Severe Intraocular Inflammation After Intravitreal Injection of Faricimab: A Single-Site Case Series of Six Patients;American Journal of Ophthalmology;2025-01

2. Multifunctional nano-in-micro delivery systems for targeted therapy in fundus neovascularization diseases;Journal of Nanobiotechnology;2024-06-20

3. Multiple Synergistic Effects of the Microglia Membrane-Bionic Nanoplatform on Mediate Tumor Microenvironment Remodeling to Amplify Glioblastoma Immunotherapy;ACS Nano;2024-05-21

4. Application of ensemble learning to augment fluorescence-based PAT and enable real-time monitoring of protein refolding;Biochemical Engineering Journal;2024-04

5. Advanced Technologies of Drug Delivery to the Posterior Eye Segment Targeting Angiogenesis and Ocular Cancer;Critical Reviews™ in Therapeutic Drug Carrier Systems;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3